NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCD E-264-1997-0-BR-04 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS BR National Stage PI9906902-4 Abandoned
NIDCD E-264-1997-0-KR-11 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS KR National Stage 1020007007737 Abandoned
NIDCD E-264-1997-0-CA-05 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN MAMMALS CA National Stage 2315746 Abandoned
NIDCD E-264-1997-0-MX-12 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS MX National Stage 006678 Abandoned
NIAID E-070-1999-0-US-01 Novel HIV Related Peptides US 60/115,430 Abandoned
NCI E-147-1991-1-US-07 Methods Of Inhibiting The Growth of Cells Bearing LewisY Antigens Useing B1,B3, or B5 Targeted Immunoconjugates US DIV 09/227,693 6287562 Abandoned PDF
NIAID E-065-1998-0-PCT-02 BROAD SPECTRUM CHEMOKINE ANTAGONIST AND USES THEREOF PCT PCT PCT/US1999/000491 Expired
NIMH E-080-1999-0-US-01 METHODS OF PROLONGING TRANSPLANT SURVIVAL USING IMMUNOTOXINS AND CO- STIMULATION BLOCKADE OF CD154 AND CD28 US 60/115,252 Abandoned
NCI E-021-1999-0-US-01 The CD4-CCR5 Interaction as a Target for Inhibitors of HIV Infection US 60/115,182 Abandoned
NCI E-040-1996-0-US-07 METHODS AND COMPOSITIONS FOR TRANSFORMING DENDRITIC CELLS AND ACTIVATING T CELLS US National Stage 09/117,764 6734014 Expired PDF
NHLBI E-047-1999-0-US-01 NMI Modulation of Signal Transduction Through Association With Stat Proteins and Other Proteins US 60/115,037 Abandoned
NCI E-231-1998-0-US-01 Lentivirus Vector System US 60/115,247 Abandoned
NCI E-210-1998-0-US-01 Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methods-- US 60/114,868 Abandoned
NCI E-094-1994-0-US-02 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 09/226,540 Abandoned
NCI E-094-1994-0-US-03 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 09/226,541 Abandoned
NCI E-039-1996-0-US-03 Anti-Viral Pharmaceutical Compositions Containing Saturated 1,2-Dithiaheterocyclic Compounds And Uses Thereof US National Stage 09/214,331 6046228 Abandoned PDF
NCI E-194-1998-0-US-01 Calcium Channel Compositions and Methods of Use Thereof US 60/114,359 Abandoned
NCI E-173-1997-0-PCT-02 MURINE INTRACISTERNAL A PARTICLE CONSTITUTIVE TRANSPOR ELEMENTS AND USES THEREOF PCT PCT PCT/US1998/027792 Expired
NHLBI E-124-1998-0-US-01 METHOD FOR MRI VENOGRAPHY AND ARTERIAL AND VENOUS DISCRIMINATION US ORD 09/221,500 6192264 Expired PDF
NCI E-200-1994-2-EP-07 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof EP National Stage 98966748.0 Abandoned
NCI E-091-1999-0-US-03 Indentification of a Transforming Fragment of Herpes Simplex Type 2 and Detection Thereof in Clinical Specimens US National Stage 09/202,918 6617103 Expired PDF
NCI E-200-1994-2-AU-04 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof AU National Stage 24496/99 Abandoned
NICHD E-010-1998-1-AU-02 The Protein Tyrosine Kinase Substrate LAT and Its Use in the Identification of (Ant) Agonists of the Kinase AU National Stage 22047/99 Abandoned
NCI E-200-1994-2-PCT-02 No_Patent_Title PCT PCT PCT/US1998/027407 Expired
NICHD E-010-1998-1-PCT-01 COMPOSITIONS AND METHODS FOR IDENTIFYING AND TESTING TYROSINE KINASE SUBSTRATES AND THEIR AGONISTS AND ANTAGONISTS (As Filed) PCT PCT PCT/US1998/027400 Expired
NIAID E-246-2001-0-PCT-02 Immunization For Ebola Virus Infection PCT PCT PCT/US1998/027364 Expired
NCI E-200-1994-2-BR-05 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof BR National Stage PI9814575-4 Abandoned
NICHD E-010-1998-1-EP-04 The Protein Tyrosine Kinase Substrate LAT and its Use in the Identification of (Ant) Agonists of the Kinase EP National Stage 98966063.4 Abandoned
NIAID E-246-2001-0-EP-03 Immunization For Ebola Virus Infection EP National Stage 98964877.9 Abandoned
NCI E-200-1994-2-IN-03 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof IN National Stage 2000/00143/CHE Abandoned
NICHD E-010-1998-1-CA-05 The Protein Tyrosine Kinase Substrate LATand It's Use in the Identification of (Ant) Agonists of the Kinase CA National Stage 2316769 Abandoned
NCI E-200-1994-2-CA-06 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof CA National Stage 2313487 Abandoned
NCI E-151-1998-0-US-01 Water-Insoluble Drug Delivery System US 60/113,423 Abandoned
NCI E-133-1991-0-US-05 HUMAN CRIPTO-RELATED GENE US CON 09/222,246 Abandoned
NCI E-029-1999-0-PCT-02 Brefeldin a Derivatives PCT PCT PCT/US98/27000 Expired
NCI E-068-1993-1-US-08 Methods of Assesing MHC Class I Expression and Proteins Capable of Modulation Class I Expression US DIV 09/215,989 Abandoned
NCI E-068-1993-1-US-07 Method of Assessing MHC Class I Expression and Proteins Capable of Modulation Class I Expression US DIV 09/215,712 Abandoned
NIDCR E-106-1998-0-US-01 NOVEL METHODS AND COMPOSITIONS FOR THE PREPARATION OF SILYL DERIVATIVES OF RESINS US ORD 09/213,892 6177534 Expired PDF
NCI E-002-1996-1-US-14 NUCLEIC ACID ENCODING MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS US DIV 09/215,035 6153430 Expired PDF
NINDS E-106-1995-0-US-08 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY US CON 09/212,165 6669935 Abandoned PDF
NCI E-124-1996-0-US-03 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I (FRAG1), RELATED PROTEINS AND METHODS US National Stage 09/202,548 6323316 Expired PDF
NCI E-075-1998-0-US-01 Method for Deoxygenation of Nucleoside Secondary Alcohols US 60/112,327 Abandoned
NHLBI E-067-1996-0-US-06 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD US National Stage 09/202,459 6520911 Expired PDF
NIAID E-133-1993-0-US-12 BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS US DIV 09/210,288 6392026 Abandoned PDF
NICHD E-070-1998-0-US-01 (DESIGNS FOR) NON-CONTACT LASER CAPTURE MICRODISSECTION US 60/111,662 Abandoned
NCI E-022-2006-1-US-02 Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor US DIV 09/209,180 Abandoned
NCI E-267-1997-0-PCT-02 NEW METHOD OF PREPARATION OF THE CLINICALLY ACTIVE ANTI-HIV AGENT FDDA PCT PCT PCT/US1998/026109 Expired
NCI E-256-1998-0-US-01 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof US 60/111,582 Abandoned
NIDDK E-225-1995-2-US-08 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. US National Stage 09/117,598 6066642 Abandoned PDF
NINDS E-153-1991-1-US-04 DEFECTIVE,INTERFERING HIV PARTICLES US DIV 09/206,497 Abandoned